HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xi-Juan Chen Selected Research

Neoplasms (Cancer)

1/2021Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy.
1/2020Association between APOBEC3H-Mediated Demethylation and Immune Landscape in Head and Neck Squamous Carcinoma.
1/2018MiR-135a-5p represses proliferation of HNSCC by targeting HOXA10.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xi-Juan Chen Research Topics

Disease

3Neoplasms (Cancer)
01/2021 - 01/2018
1Squamous Cell Carcinoma of Head and Neck
01/2020
1Cystic Fibrosis (Mucoviscidosis)
03/2006
1Infections
08/2004

Drug/Important Bio-Agent (IBA)

1DNA (Deoxyribonucleic Acid)IBA
01/2020
14-bromobenzoyl-(alpha-aminoisobutyric acid)(5)-leucyl-(alpha-aminoisobutyric acid)(2)-methoxy (BALA)IBA
01/2018
1CationsIBA
03/2006
1Pimozide (Orap)FDA Link
03/2006
1Epithelial Sodium ChannelsIBA
08/2004

Therapy/Procedure

2Immunotherapy
01/2021 - 01/2020